-

VRTV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Veritiv Corporation Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Veritiv Corporation (NYSE: VRTV) to an affiliate of Clayton, Dubilier & Rice, LLC for $170.00 per share in cash is fair to Veritiv shareholders.

Halper Sadeh encourages Veritiv shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Veritiv and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Veritiv shareholders; (2) determine whether Clayton, Dubilier & Rice is underpaying for Veritiv; and (3) disclose all material information necessary for Veritiv shareholders to adequately assess and value the merger consideration. On behalf of Veritiv shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Veritiv shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLC

NYSE:VRTV

Release Versions

Contacts

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLC

AFBI Stock Alert: Halper Sadeh LLC is Investigating Whether Affinity Bancshares, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Affinity Bancshares, Inc. (NASDAQ: AFBI) to Fidelity BancShares (N.C.), Inc. for $23.00 per share in cash, subject to adjustment based on Affinity’s adjusted stockholders’ equity at closing.Halper Sadeh encourages Affinity shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or...

FORA Stock Alert: Halper Sadeh LLC is Investigating Whether Forian Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Forian Inc. (NASDAQ: FORA) to a consortium of investors led by Max Wygod, Chairman and Chief Executive Officer, together with certain other senior executives and existing shareholders of the Company, for $2.17 per share in cash.Halper Sadeh encourages Forian shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212)...

SLNO Stock Alert: Halper Sadeh LLC is Investigating Whether Soleno Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Soleno Therapeutics, Inc. (NASDAQ: SLNO) to Neurocrine Biosciences for $53.00 per share in cash.Halper Sadeh encourages Soleno shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Soleno and its board of directors vi...
Back to Newsroom